Drug Database
DT

DTwP-HB-Hib vaccine (Pentavac SD, SSI / Pentavac PFS, SSI)

✓ Approved

Serum Institute of India Pvt. Ltd. · 疫苗 · 疫苗

什么是 DTwP-HB-Hib vaccine?

DTwP-HB-Hib vaccine 是一种疫苗,由Serum Institute of India Pvt. Ltd.研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)、Intramuscular (IM) Injection。

药物档案

商品名Pentavac SD, SSI, Pentavac PFS, SSI
公司Serum Institute of India Pvt. Ltd.
药物类别疫苗
给药途径Injectable (Others), Intramuscular (IM) Injection
状态Approved

治疗适应症

DTwP-HB-Hib vaccine 针对 4 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Infections and infestationsDiphtheria✓ Approved
Infections and infestationsHepatitis B✓ Approved
Infections and infestationsPertussis✓ Approved
Infections and infestationsTetanus✓ Approved

相关研究文献

PubMedmedRxiv : the preprint server for health sciences2026-11-20

Hypoxic Burden Predicts Symptomatic but Not Sleep Architecture Response to CPAP Therapy in Obstructive Sleep Apnea.

Bäcker Sara S, Ehrlich Franz F, Sehr Tony T, Brandt Moritz D MD et al.

The apnea-hypopnea index (AHI) remains the standard metric for assessing obstructive sleep apnea (OSA) severity, although it does not fully capture the physiological consequences of respiratory events. Hypoxic burden (HB), which integrates the frequency, depth, and duration of oxygen desaturations, has been proposed as a more comprehensive measure of OSA-related hypoxic stress. This study compared the prognostic value of HB and AHI for subjective and objective treatment outcomes in patients undergoing continuous positive airway pressure (CPAP) therapy. Data from 412 patients with OSA who underwent diagnostic and CPAP-treated polysomnography were analyzed, including 52 patients with available follow-up questionnaires. HB was calculated using a validated event-based algorithm. Multivariable regression models were used to predict patient-reported outcomes and changes in sleep architecture, adjusted for age, sex and body mass index. HB consistently demonstrated stronger associations with symptomatic outcomes than AHI. Models including HB showed improved model fit and explained variance. HB remained independently associated with lower follow-up fatigue and better sleep quality after adjustment for AHI. In contrast, AHI was the dominant predictor of objective sleep architecture improvements, including increases in N3 sleep, reductions in N1 sleep, and reductions in arousal index. HB provided additional independent information only for changes in arousal burden. These findings suggest that HB and AHI capture complementary dimensions of OSA severity. While AHI primarily reflects sleep fragmentation and physiological response to CPAP, HB appears more closely related to subjective treatment benefit. Incorporating HB alongside AHI may improve clinical phenotyping and prediction of treatment response in OSA.

PMID 43060605
阅读全文 →
PubMedBMC gastroenterology2026-11-20

Single-cell and spatial transcriptomics reveal glycolytic remodeling and ENO1-associated metabolic vulnerability in hepatoblastoma.

Wu Xiongwei X, Zhou Pingping P, Wu Siyan S, Zhang Zhengshou Z et al.

Hepatoblastoma (HB) is the most common malignant liver tumor in children; however, the contribution of glycolytic metabolic reprogramming to HB development and progression remains incompletely characterized. We integrated single-cell RNA sequencing and spatial transcriptomic datasets of HB from the GEO database. Glycometabolic pathway activity was quantified using scMetabolism, and pseudotime and transcription factor activity analyses were performed to characterize regulatory programs associated with glycolytic reprogramming. CellChat and spatial transcriptomics were applied to examine predicted tumor-immune communication. hdWGCNA combined with differential expression analysis was used to prioritize glycolysis-associated genes. ENO1 was further evaluated by in silico network perturbation, two independent shRNAs in vitro, and computational compound prioritization followed by molecular docking and a 100-ns molecular dynamics simulation. The single-cell atlas resolved 10 major cell types and revealed elevated glycolysis/gluconeogenesis pathway scores in malignant epithelial cells. Pseudotime analysis showed increasing glycolytic activity along the inferred epithelial trajectory. CellChat predicted enhanced MDK-NCL communication between Glyco_High tumor cells and neutrophils, while spatial analysis showed regional concordance between MDK/NCL co-expression and high-glycolysis areas. hdWGCNA identified three glycolysis-associated candidate genes: ENO1, AKR1A1, and AHCY. In silico ENO1 perturbation was associated with altered inferred regulatory activity of approximately 2.1% of genes. Two independent ENO1-targeting shRNAs produced concordant reductions in proliferation, colony formation, lactate production, and glucose consumption in HepG2 and Huh6 cells. BRD-K14653796 was computationally prioritized, and the modeled ENO1-compound complex remained conformationally stable under the specified simulation conditions. This study characterizes glycolytic heterogeneity in HB at single-cell and spatial resolution and nominates ENO1 as a candidate metabolic vulnerability in CNV-high putative malignant epithelial cells. It also highlights a computationally predicted MDK-NCL-associated tumor-immune communication pattern and provides testable hypotheses for future preclinical validation.

PMID 43058500
阅读全文 →
PubMedZhongguo shi yan xue ye xue za zhi2026-11-20

[Analysis of Clinical Symptoms in Patients with Different Genotypes of HbH Disease].

Su Yin-Feng YF, Lai Jin-Xin JX, Zhang Xin-Qiang XQ, Liu Sheng-Nan SN et al.

To explore the correlation between genotypes and clinical phenotypes in patients with hemoglobin H (HbH) disease in Guangdong and to provide a reference for clinical diagnosis and treatment. A total of 153 patients diagnosed with HbH disease by genetic testing at Guangdong Provincial People's Hospital were enrolled. Routine blood tests were used to analyze red blood cell parameters, Hb electrophoresis was performed to determine Hb components, and Gap-PCR and PCR-RDB assays were used for thalassemia genotyping. In this region, deletional HbH was the predominant genotype, accounting for 79.04%. Unlike deletional HbH, non-deletional HbH exhibited more severe anemia, characterized by lower red blood cell count (RBC) and Hb level, but higher mean corpuscular volume (MCV) and mean corpuscular hemoglobin (MCH). Significant differences in RBC, MCV and MCH were observed between patients with deletional HbH disease and those with the non-deletional subtype (P<0.05). The blood transfusion rate and the incidence of splenomegaly and jaundice in patients with non-deletional HbH were significantly higher than those in deletional patients (61.90% vs. 26.53%, 91.67% vs. 53.40%, 79.17% vs. 36.45%, respectively). The hematological parameters and severity of clinical symptoms in patients with HbH disease are closely associated with the genotype of α-globin. Patients with non-deletional HbH disease (excluding --SEA/ααWS) present more severe hematological abnormalities and clinical symptoms. The HbH content is correlated with the severity of the disease and can provide a reference for disease evaluation.

PMID 43059238
阅读全文 →
PubMedZhongguo shi yan xue ye xue za zhi2026-11-20

[Clinical Significance and Prognostic Characteristics of DIS3 Mutation in Multiple Myeloma].

Gui Lin L, Zhou Fang F, Wang Fei F, Song Hui-Hui HH et al.

To investigate the clinical significance of DIS3 mutations in multiple myeloma (MM) and analyze the clinical characteristics and prognosis of MM patients with DIS3 mutations. The clinical data of 124 MM patients who were newly diagnosed and tested by next-generation sequencing in the Department of Hematology, Zhongda Hospital Southeast University and the Department of Hematology, the Affiliated Jiangning Hospital of Nanjing Medical University from January 1, 2020 to December 31, 2024 were retrospectively analyzed. Measurable residual disease (MRD), overall survival (OS) time and progression-free survival (PFS) time were used as prognostic evaluation indicators. Univariate prognostic analysis was performed on MM patients with DIS3 mutations using Kaplan-Meier survival curves combined with the log-rank test. Multivariate analysis was conducted via the Cox regression model to screen independent risk factors affecting the prognosis of such patients. Among the 124 patients, DIS3 mutation was detected in 21 patients, with a mutation rate of 16.9%. Univariate survival analysis was performed on 124 patients. The results showed that DIS3 mutation, creatinine, extramedullary disease (EMD) at initial diagnosis, MRD, autologous stem cell transplantation (ASCT), hemoglobin (Hb), β2-microglobulin (β2-MG) were related to OS (all P<0.05), while DIS3 mutation, creatinine, EMD at initial diagnosis, MRD, Hb, β2-MG, ASCT, and gender were related to PFS (all P<0.05). Further multivariate Cox regression analysis showed that MRD+ was an independent risk factor for OS (HR>1,P<0.05), while Hb ≥80 g/L was an independent protective factor for OS (HR>1,P<0.05). In addition, both MRD+and DIS3 mutation were independent risk factors for PFS (HR>1,P<0.05). Univariate survival analysis was performed on 21 patients with DIS3 mutation. The results showed that 13q-, EMD at initial diagnosis, MRD and Hb were related to both OS and PFS (all P<0.05). Further multivariate Cox regression analysis showed that 13q-, MRD+ and EMD at initial diagnosis were independent risk factors affecting OS in patients with DIS3 mutations (HR>1,P<0.05), while MRD+ and EMD at initial diagnosis were independent risk factors affecting PFS in patients with DIS3 mutations (HR>1,P<0.05). DIS3 mutation is an independent risk factor affecting PFS of MM patients. MM with DIS3 mutation has a poor prognosis, and DIS3 can be used as a new prognostic marker for MM.

PMID 43059233
阅读全文 →
PubMedJournal of global health2026-11-20

Future vaccine priorities in Cambodia: preparedness for emerging infectious diseases.

Puth Sao S, Loeurng Vandara V

Cambodia has achieved substantial progress in immunisation over the past two decades, culminating in one of Southeast Asia's most successful COVID-19 vaccination campaigns. However, the epidemiological landscape is rapidly changing. Climate change, environmental degradation, urbanisation, increasing regional mobility, and intensified human-animal interactions are increasing the risk of emerging infectious diseases, placing Cambodia at the frontline of future epidemic and pandemic threats. Although national vaccine policy has traditionally focused on childhood immunisation, preparedness for emerging infectious diseases requires a broader strategy that integrates pathogen surveillance, genomic monitoring, regulatory readiness, rapid vaccine platforms, and One Health collaboration. Here, we highlight the need for Cambodia to transition from a vaccine delivery agenda toward a broader vaccine preparedness agenda. We propose a national framework centred around surveillance-informed vaccine prioritisation, strengthened laboratory and genomic capacity, resilient vaccine delivery systems, sustainable financing, and regional partnerships. Such an approach could enhance Cambodia's preparedness for pathogens including H5N1, dengue, Japanese encephalitis, rabies, and future Disease X scenarios, while strengthening its contribution to regional health security.

PMID 43061856
阅读全文 →
PubMedmedRxiv : the preprint server for health sciences2026-11-20

Ontology-Based SEA-CDM Integration for Vaccine Clinical Trials: Query, Similarity, and Design Recommendation.

Zhu Jiadong J, Yeh Feng-Yu Leo FL, Zheng Jie J, He Yongqun Oliver YO

gov provides valuable information for vaccine research, but fragmented data structures and inconsistent vaccine naming complicate systematic cross-trial analysis. The Study-Experiment-Assay Common Data Model (SEA-CDM) provides a standardized structure for biomedical study data, while biomedical ontologies supply semantic relationships among concepts. We extracted 9,147 vaccine-related study records from the Aggregate Analysis of ClinicalTrials.gov (AACT) database, mapped their records into SEA-CDM, and linked vaccine products and reported adverse events (AEs) to the Vaccine Ontology (VO) and Ontology of Adverse Events (OAE), respectively. Building on the existing Ontology-based SEA Network (OSEAN), we organized the integrated data into relational tables and a Neo4j knowledge graph while retaining links to original registrations. We evaluated three applications to assess semantic trial retrieval, context-aware AE ranking and trial similarity, and trial design recommendation. First, VO-based query expansion retrieved 41 candidate RNA vaccine trials compared with 16 using exact VO identifier matching. Second, a context-aware AE ranking model incorporating SEA-CDM features and VO-derived vaccine families improved recall@10 from 0.317 to 0.383 over a frequency-based baseline. TransE and CompGCN embeddings achieved Hits@10 of 0.950 and 0.946, respectively, for retrieving trials sharing the same VO identifier within disease-specific candidate sets. Third, an ontology-based clinical trial design recommendation model was developed using several machine learning methods under leave-one-Material-out evaluation across 23 vaccine classes, although performance varied across classes. These findings demonstrate how structural and semantic integration can support multiple clinical trial analyses using vaccine studies as a case study. This framework provides a foundation for extending ontology-supported data integration and analysis to other clinical research domains.

PMID 43059852
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多DTwP-HB-Hib vaccine